Fortress Biotech (NASDAQ: FBIO)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-15 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.280 | -0.100 | 0.1800 | ||||
REV | 23.925M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Fortress Biotech (NASDAQ: FBIO) through any online brokerage.
Other companies in Fortress Biotech’s space includes: Alzamend Neuro (NASDAQ:ALZN), Anixa Biosciences (NASDAQ:ANIX), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS) and Portage Biotech (NASDAQ:PRTG).
The latest price target for Fortress Biotech (NASDAQ: FBIO) was reported by Roth Capital on Tuesday, April 20, 2021. The analyst firm set a price target for 5.00 expecting FBIO to rise to within 12 months (a possible 525.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Fortress Biotech (NASDAQ: FBIO) is $0.8 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Fortress Biotech.
Fortress Biotech’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for Fortress Biotech.
Fortress Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.